User:LostBurger/sandbox

BrainKey
BrainKey is a privately held neuroscience company based in San Francisco, California. It is best known for providing a direct-to-consumer personal brain cloud-based dashboard in which the customer’s brain MRI is analyzed using artificial intelligence to map the brain, track changes over time, generate personalized insights into the brain structure and relate these to relevant neuroscience and health research.

Additionally, customers can draw and annotate their brain MRI directly through the dashboard.

Beyond its direct to consumer product, BrainKey participates in research into neurodegenerative and psychiatric disease with University collaborators in the US, Europe, and Japan. For example 1

History
BrainKey was founded by neuroscientist Owen Phillips, Ph.D., and computational biologist Ben Kotopka, Ph.D. in 2018 while they were at Stanford University.

According to the BrainKey website, BrainKey was started to democratize access to brain research so that anyone, anywhere in the world can benefit from developments in brain science.

Funding
BrainKey is a YCombinator Winter 2019 company. Additionally, it is backed by venture capital firms Soma Capital, and Social Starts.

Product
In 2019, BrainKey was the first company to offer a personal brain dashboard to customers who previously had a brain MRI. BrainKey’s goal is to help non-expert users who have had an MRI have more controls of their MRI so they could view, interact in 3D, learn from, track changes over time and annotate their scan directly.

Before BrainKey, the only tools for viewing MRI data were designed for expert users such as radiologists or academic researchers. For example, free academic research tools such as Freesurfer and Brainsuite offer some of the functionality of BrainKey but are geared towards academics focused on large neuroscience research studies. On the clinical side, a suite of new new AI radiologist tools are emerging such as Neuroquant, and Icometrix but these are geared towards clinicians improving their workflow and clinical diagnosis.

BrainKey gives it’s users the option to print their brain in 3D.

Clinical Use
BrianKey product is not intended for use in making clinical decisions. It is not FDA approved. The product is geared towards individual consumers and not towards clinicians.

Privacy
BrainKey’s privacy policy follows the consent and privacy guidelines laid out by GDPR. The GDPR is a set of rules/regulations that helps individuals take control of his/her data information that is collected, used and stored digitally or in a structured filing system on paper, and restricts a company's use of personal data.

BrainKey’s stated long term goal is to contribute to fighting neurological and psychiatric illness. To that end, the user’s data is used in research. However, individual users can control how they want their data to be used. To that end, BrainKey seeks to give users easy access to explicit control over what data they want to share and when and which data they want to remove from BrainKey.